Leonard Rickey Investment Advisors P.L.L.C. Gilead Sciences, Inc. Transaction History

Leonard Rickey Investment Advisors P.L.L.C.

$433 Million
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $238,464 - $299,827	-3,840 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $2,459 - $2,856	34 Added 0.89%	3,840 $295,000
Q1 2020 Apr 28, 2020	BUY	$62.63 - $80.22 $12,776 - $16,364	204 Added 5.66%	3,806 $285,000
Q4 2019 Jan 07, 2020	BUY	$61.62 - $67.78 $8,503 - $9,353	138 Added 3.98%	3,602 $234,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $7,313 - $8,073	-117 Reduced 3.27%	3,464 $220,000
Q2 2019 Jul 10, 2019	SELL	$61.87 - $69.38 $4,949 - $5,550	-80 Reduced 2.19%	3,581 $242,000
Q1 2019 Apr 10, 2019	SELL	$62.53 - $70.05 $3,876 - $4,343	-62 Reduced 1.67%	3,661 $238,000
Q4 2018 Jan 17, 2019	SELL	$60.54 - $79.0 $6,659 - $8,690	-110 Reduced 2.87%	3,723 $233,000
Q3 2018 Oct 23, 2018	BUY	$71.28 - $78.92 $427 - $473	6 Added 0.16%	3,833 $296,000
Q2 2018 Jul 17, 2018	BUY	$64.88 - $75.68 $389 - $454	6 Added 0.16%	3,827 $271,000
Q1 2018 Apr 25, 2018	SELL	$72.84 - $88.8 $8,813 - $10,744	-121 Reduced 3.07%	3,821 $288,000
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $280,473 - $329,235	3,942	3,942 $282,000

Others Institutions Holding GILD

# of Institutions

1,925

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.7 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.77 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.47 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.32 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leonard Rickey Investment Advisors P.L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Leonard Rickey Investment Advisors P.L.L.C. with notifications on news.

Account